Navigating the final stages for a loved one with dementia can be an emotional and challenging experience. Recognizing the ...
Access to the new Alzheimer's drugs is limited by strict eligibility criteria, long wait times, and a lack of infusion ...
As research continues, those involved say this would be a game changer, especially for patients with very limited options.
The last few years have seen notable progress ... Treatments approved for Alzheimer’s in the mild cognitive impairment and mild dementia stages are being tested in persons who are cognitively ...
The FDA approves a new maintenance dosing regimen for lecanemab (Leqembi; Eisai) in patients with early-stage Alzheimer ...
("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s ...
A new Alzheimer’s treatment at Hancock Regional Hospital has both doctors and patients feeling cautiously optimistic.